abstract |
The present invention relates to a diagnostic composition, diagnostic kit and diagnostic method for breast cancer using autoantibodies against TXNL2 (Thioredoxin-like 2) protein or fragment thereof. The present invention allows for more accurate and early diagnosis of breast cancer by detecting autoantibodies against TXNL2 (Thioredoxin-like 2) protein or fragment thereof. |